首页> 美国政府科技报告 >Generalized Urticaria to Cyclophosphamide: Type I Hypersensitivity to an Immunosuppressive Agent.
【24h】

Generalized Urticaria to Cyclophosphamide: Type I Hypersensitivity to an Immunosuppressive Agent.

机译:广泛性荨麻疹对环磷酰胺:I型对免疫抑制剂的超敏反应。

获取原文

摘要

A 6-yr-old white boy, Patient L. B., who was receiving cyclophosphamide (CY) for chemotherapy of a localized undifferentiated small cell sarcoma of the chest wall, developed generalized urticaria on three separate occasions immediately after CY administration. Serum samples were obtained 2 and 5 wk after the patient's last reaction. Homocytotropic antibody activity to CY was found in the 2-wk postreaction sample by Prausnitz-Kustner type passive transfer skin testing to chimpanzees. This homocytotropic antibody was found to be of the IgE type, by means of an in vitro double antibody coprecipitation assay measuring binding of free 14C-CY by specific immunoglobulin E and G fractions. Sera from 3 CY-treated patients who did not have adverse reactions to the drug and 6 normal, age-matched volunteers were used as control samples for the coprecipitation assay. None of the 3 CY-treated control patients had significant binding of 14C-CY by IgE when compared to normal individuals. However, it was found that all CY-treated patients had significant binding of 14C-CY by their IgG fraction when compared normal subjects. (Author)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号